High Programmed Death Ligand 1 Expression with Low T-Cell Infiltration Densities Predict Poor Survival in Gastric Cancer Patients

被引：0

作者：

Teh, Jun Liang ^{[1
]}

Fazreen, Zul ^{[1
]}

Asuncion, Bernadette R. ^{[1
]}

So, Jimmy By ^{[1
]}

Soong, Richie ^{[1
]}

机构：

[1] Natl Univ Hlth Syst, Canc Sci Inst Singapore, Singapore, Singapore

来源：

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2016年 / 223卷 / 04期

关键词：

D O I：

10.1016/j.jamcollsurg.2016.06.040

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：S14 / S15

页数：4

共 50 条

[41] Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
Chia-Wei Li
Seung-Oe Lim
Weiya Xia
Heng-Huan Lee
Li-Chuan Chan
Chu-Wei Kuo
Kay-Hooi Khoo
Shih-Shin Chang
Jong-Ho Cha
Taewan Kim
Jennifer L. Hsu
Yun Wu
Jung-Mao Hsu
Hirohito Yamaguchi
Qingqing Ding
Yan Wang
Jun Yao
Cheng-Chung Lee
Hsing-Ju Wu
Aysegul A. Sahin
James P. Allison
Dihua Yu
Gabriel N. Hortobagyi
Mien-Chie Hung
Nature Communications, 7
[42] Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma
Zhang, Yang
Wang, Lei
Li, Yuan
Pan, Yunjian
Wang, Rui
Hu, Haichuan
Li, Hang
Luo, Xiaoyang
Ye, Ting
Sun, Yihua
Chen, Haiquan
ONCOTARGETS AND THERAPY, 2014, 7 : 567 - 573
[43] Insulin-like growth factor 1 receptor expression correlates with programmed death ligand 1 expression and poor survival in non-small cell lung cancer
Nagamine, Hiroaki
Yashiro, Masakazu
Mizutani, Megumi
Sugimoto, Akira
Matsumoto, Yoshiya
Tani, Yoko
Sawa, Kenji
Kaneda, Hiroyasu
Yamada, Kazuhiro
Watanabe, Tetsuya
Asai, Kazuhisa
Suzuki, Satoshi
Kawaguchi, Tomoya
PLOS ONE, 2024, 19 (10):
[44] Programmed Death Ligand 1 Expression as an Immunotherapy Biomarker for Patients with Lung Cancer
Boyle, T. A.
Yu, H.
Ellison, K.
Kowalewski, A. A.
Rozeboom, L.
Rivard, C.
Chan, D.
Hirsch, F. R.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 825 - 825
[45] The expression of programmed death-ligand 1 in patients with invasive breast cancer
Meng, Yi
Wu, Hongyan
Yao, Yongzhong
Li, Rong
GLAND SURGERY, 2020, 9 (06) : 2106 - 2115
[46] Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer
Nero, Camilla
Romito, Ilaria
Spadola, Saveria
Romito, Alessia
Turco, Luigi Carlo
Cosentino, Francesco
De Ninno, Maria
Catena, Ursula
Nardone, Alessandra De Cicco
Moroni, Rossana
Zannoni, Gianfranco
Fagotti, Anna
Scambia, Giovanni
FERTILITY AND STERILITY, 2022, 117 (01) : 160 - 168
[47] Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors
Zhang, Lin
Qiu, Miaozhen
Jin, Ying
Ji, Jiao
Li, Baoxia
Wang, Xueping
Yan, Shumei
Xu, Ruihua
Yang, Dajun
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (09): : 11084 - 11091
[48] Expression of programmed death receptor ligand 1 in melanoma may indicate tumor progression and poor patient survival
Oba, Junna
Nakahara, Takeshi
Abe, Takeru
Hagihara, Akihito
Moroi, Yoichi
Furue, Masutaka
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : 954 - 956
[49] Immunohistochemical Scores for Programmed Death Ligand-1 (PD-L1) Expression and Prognostic in Patients with Gastric Cancer
Pereira, Marina A.
Ramos, Marcus Fernando Kodama P.
Ribeiro e Ribeiro, Renan
Dias, Andre R.
Ribeiro, Ulysses, Jr.
Zilberstein, Bruno
Cecconello, Ivan
Mello, Evandro Sobroza
Castria, Tiago B.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : E208 - E208
[50] Programmed Death Ligand-1 Expression Is Associated With Poor Disease Free Survival in Salivary Gland Carcinomas
Mukaigawa, Takashi
Hayashi, Ryuichi
Hashimoto, Kazuki
Ugumori, Toru
Hato, Naohito
Fujii, Satoshi
JOURNAL OF SURGICAL ONCOLOGY, 2016, 114 (01) : 36 - 43

← 1 2 3 4 5 →